University of Oregon, Health Policy Research Group, Eugene, OR 97403-1209, USA.
Institute for Critical Junctures, Bellingham, WA, USA.
Patient Educ Couns. 2017 Jul;100(7):1276-1279. doi: 10.1016/j.pec.2017.03.019. Epub 2017 Mar 16.
We assess how patient activation is associated with behaviors and experiences of people with cancer, including: understanding risks; making treatment decisions; communicating with providers; coping with symptoms; and adhering to regimens.
The study utilizes survey data from six surveys each including 500 cancer survivors. Multivariate analyses are presented.
Higher activated patients are more than 9 times more likely to feel their treatment plans reflect their values, 4.5 times more likely to cope with side effects, and almost 3.3 times more likely to initiate a healthier diet after their diagnosis, than are less activated patients. Less activated patients are less likely understand their diagnosis, to follow treatment regimens, and to be satisfied with their care.
The findings show that all along the care continuum, patient activation is associated with differences in experiences.
The findings point to the value of assessing patients' activation levels at the beginning of their cancer experience.
我们评估患者的积极性如何与癌症患者的行为和体验相关,包括:了解风险;做出治疗决策;与医护人员沟通;应对症状;以及坚持治疗方案。
本研究使用了来自六个调查的调查数据,每个调查都包括 500 名癌症幸存者。呈现了多变量分析。
与积极性较低的患者相比,积极性较高的患者更有可能感到他们的治疗计划反映了他们的价值观,更有可能应对副作用,并且在诊断后几乎有近 3.3 倍的可能性开始更健康的饮食。积极性较低的患者不太可能了解自己的诊断,遵循治疗方案,对自己的护理感到满意。
研究结果表明,在整个护理过程中,患者的积极性与体验差异相关。
研究结果表明,在癌症患者的初始阶段评估其积极性水平具有价值。